1Hall DR, Odendaal HJ, Steyn DW, et al. Expectant management of early onset, severe pre-eclampsia: maternal outcome [J].BJOG,2000,107(10) : 1252-1257,1258-1264.
3Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia [J]. Hypertension ,2005,46 : 1270-1274.
4Wiwanitkit V. Correlation between plasminogen activator inhibitor-1 4G/5 G polymorphism and pre-eclampsia: an appraisal [J].Arch Gynecol Obstet,2006,273 ( 6 ) : 322 -324.
5Heikila A, Tuomisto T, Hakkinen SK,et al. Tumor suppressor and growth regulatory gene are overexpressed in severe early-onset preeclampsia-an array study on case-specific human preeclamptic placental tissue [J]. Acta Obstet Gynecol Scand, 2005,84 ( 7 ) :679-689.
6Kadyrov M, Kingdom JC, Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction [J]. Am J Obstet Gynecol,2006,194 (2) :557-563.
7Crispi F, Dominguez C, Llurba E, et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction[J]. Am J Obstet Gynecol, 2006, Epubahead of print.
8Donker RB, Molema G, Faas MM, et al. Absence of in vivo generalized pro-inflammatory endothelial activation in severe , earlyonset preeclampsia [J]. J Soc Gynecol Invest,2005,12 ( 7 ) : 518 -528.
9Zhong XY, Gebhardt S, HiUermann R, et al. Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia[J]. Clin Chem,2005,51 : 1730-1733.
10Zhong XY, Gebhardt S, Hillermann R, et al. Circulatory nucleosome levels are significantly increased in early and late-onset preeclampsia [J]. Prenat Diagn ,2005,25 ( 8 ) :700-703.
2Branch DW, Andres R, Digre KB, et al. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol, 1989,73:541-545.
3Sibai BM, Mercer BM, Schiff E, et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol,1994,171:818-822.
4Hall DR, Odendaal HJ, Steyn DW, et al. Expectant management of early onest, severe pre-eclampsia: maternal outcome. BJOG ,2000,107:1252-1257.
5Cunningham FC, Gant NF, Leveno KJ, eds. Williams Obstetrics. 21st ed. New York: McGraw-Hill ,2001. 569-570.
6Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?Am J Obstet Gynecol, 1999,180:221-225.
7Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol,1998,179:1632-1639.
8Hall DR, Odendaal HJ, Kirsten GF, et al. Expectant management of early onest, severe pre-eclampsia: perinatal outcome. BJOG,2000,107:1258-1264.
9Odendaal HJ, Pattinson RC, Bam R, et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol, 1990, 76:1070-1075.
10ONAH H E,ILOABACHIE G C.Conservative mana-gement of early-onset preeclampsia and fetomaternal outcome in Nigerians [J].J Obstet Gynaecol,2002,22(4):357-362.
9[1]Meredith JE,Winitz S,Lewis JM,et al.The regulation of growth and intracellular signaling by integrins.Endocrine Rev,1996,17:207-220.
10[2]Li HW,Cheung AN,Tsao SW,et al.Expression of E-cadherin and Beta-Catenin in trophoblastic tissue innormal and pathological pregnancies.Int Socie Gynecol Pathol,2003,22:63-70.
